0.00 - 0.01
0.00 - 0.02
289 / 496.9K (Avg.)
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
No Data
No Data available this quarter, please select a different quarter.
4.14%
Less D&A growth vs. ECL.AX's 75.92%, reducing the hit to reported earnings. David Dodd would confirm that core assets remain sufficient.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
31.13%
Lower 'other non-cash' growth vs. ECL.AX's 332.89%, indicating steadier reported figures. David Dodd would confirm no missed necessary write-downs or gains.
37.28%
Operating cash flow growth below 50% of ECL.AX's 82.56%. Michael Burry would see a serious shortfall in day-to-day cash profitability.
95.42%
Some CapEx rise while ECL.AX is negative at -373.03%. John Neff would see competitor possibly building capacity while we hold back expansions.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
25.72%
Less 'other investing' outflow yoy vs. ECL.AX's 173.09%. David Dodd would see a stronger short-term cash position unless competitor invests more wisely.
37.28%
Lower net investing outflow yoy vs. ECL.AX's 82.56%, preserving short-term cash. David Dodd would confirm expansions remain sufficient.
No Data
No Data available this quarter, please select a different quarter.
-100.00%
Negative yoy issuance while ECL.AX is 0.00%. Joel Greenblatt sees a near-term advantage in avoiding dilution unless competitor invests more effectively with the new shares.
No Data
No Data available this quarter, please select a different quarter.